Source:http://linkedlifedata.com/resource/pubmed/id/19837366
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-10-19
|
pubmed:abstractText |
Monoclonal antibodies that effectively neutralize HIV-1 have been widely sought, yet few have been isolated. Now, technological advances in sera evaluation, B cell stimulation, microneutralization, and antibody cloning have allowed Burton and colleagues to identify two broadly neutralizing monoclonal antibodies, PG9 and PG16, which provide insights for HIV vaccine design.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1934-6069
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
22
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
292-4
|
pubmed:meshHeading |
pubmed-meshheading:19837366-Antibodies, Monoclonal,
pubmed-meshheading:19837366-Antibodies, Neutralizing,
pubmed-meshheading:19837366-B-Lymphocytes,
pubmed-meshheading:19837366-HIV Antibodies,
pubmed-meshheading:19837366-HIV-1,
pubmed-meshheading:19837366-Humans,
pubmed-meshheading:19837366-Models, Biological
|
pubmed:year |
2009
|
pubmed:articleTitle |
Mining the B cell repertoire for broadly neutralizing monoclonal antibodies to HIV-1.
|
pubmed:affiliation |
Vaccine Research Center, NIAID, National Institutes of Health, Bethesda, MD 20892, USA.
|
pubmed:publicationType |
Journal Article
|